50 related articles for article (PubMed ID: 16550603)
1. Prediction of treatment outcome by cisplatin-DNA adduct formation in patients with stage III/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin-radiation (RADPLAT).
Hoebers FJ; Pluim D; Verheij M; Balm AJ; Bartelink H; Schellens JH; Begg AC
Int J Cancer; 2006 Aug; 119(4):750-6. PubMed ID: 16550603
[TBL] [Abstract][Full Text] [Related]
2. The superselective intra-arterial infusion of cisplatin and concomitant radiotherapy (RADPLAT) is effective for metastatic lymph nodes in head and neck squamous cell carcinoma.
Kano S; Suzuki T; Yoshida D; Tsushima N; Hamada S; Yasuda K; Uchinami Y; Aoyama H; Homma A
Int J Clin Oncol; 2023 Sep; 28(9):1121-1128. PubMed ID: 37289379
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin intrastrand adducts sensitize DNA to base damage by hydrated electrons.
Behmand B; Wagner JR; Sanche L; Hunting DJ
J Phys Chem B; 2014 May; 118(18):4803-8. PubMed ID: 24779712
[TBL] [Abstract][Full Text] [Related]
4. Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells-an in-vitro study.
Brunner TF; Probst FA; Troeltzsch M; Schwenk-Zieger S; Zimmermann JL; Morfill G; Becker S; Harréus U; Welz C
Head Face Med; 2022 Jun; 18(1):21. PubMed ID: 35768853
[TBL] [Abstract][Full Text] [Related]
5. Tobacco carcinogen metabolites and DNA adducts as biomarkers in head and neck cancer: potential screening tools and prognostic indicators.
Khariwala SS; Hatsukami D; Hecht SS
Head Neck; 2012 Mar; 34(3):441-7. PubMed ID: 21618325
[TBL] [Abstract][Full Text] [Related]
6. Post-treatment magnetic resonance imaging predicts outcomes of maxillary sinus cancer treatment using super-selective intra-arterial infusion of high-dose cisplatin with concomitant radiotherapy (RADPLAT).
Yamauchi H; Baba A; Ogino N; Matsushima S; Ashida H; Nagaoka M; Ojiri H
Auris Nasus Larynx; 2024 Apr; 51(4):631-635. PubMed ID: 38626697
[TBL] [Abstract][Full Text] [Related]
7. Pterygoid Muscle Necrosis Caused by Radiation and Intra-Arterial Cisplatin Infusion Chemotherapy (RADPLAT): A Case Report.
Miyamoto K; Sato M; Koike S; Kimura T; Abe D; Wakasaki T; Kitano M; Yasumatsu R
Case Rep Oncol; 2023; 16(1):1475-1481. PubMed ID: 38028578
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamics and biodistribution of [195mPt]cisplatin(CISSPECT®) in head and neck squamous cell carcinoma.
de Roest RH; Stigter van Walsum M; van der Schilden K; Brakenhoff RH
EJNMMI Res; 2024 Mar; 14(1):22. PubMed ID: 38424294
[TBL] [Abstract][Full Text] [Related]
9. Nutritional Support of Crocin on Neurobehavioral Disabilities Induced by Cisplatin-Based Chemotherapy in Rats.
Ghotbeddin Z; Peysokhan M; Dezfouli AM; Iraee MA
Neurochem Res; 2024 Mar; 49(3):649-659. PubMed ID: 38010604
[TBL] [Abstract][Full Text] [Related]
10. Sensitive CometChip assay for screening potentially carcinogenic DNA adducts by trapping DNA repair intermediates.
Ngo LP; Owiti NA; Swartz C; Winters J; Su Y; Ge J; Xiong A; Han J; Recio L; Samson LD; Engelward BP
Nucleic Acids Res; 2020 Feb; 48(3):e13. PubMed ID: 31822921
[TBL] [Abstract][Full Text] [Related]
11. Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss.
Brock PR; Maibach R; Childs M; Rajput K; Roebuck D; Sullivan MJ; Laithier V; Ronghe M; Dall'Igna P; Hiyama E; Brichard B; Skeen J; Mateos ME; Capra M; Rangaswami AA; Ansari M; Rechnitzer C; Veal GJ; Covezzoli A; Brugières L; Perilongo G; Czauderna P; Morland B; Neuwelt EA
N Engl J Med; 2018 Jun; 378(25):2376-2385. PubMed ID: 29924955
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin generates oxidative stress which is accompanied by rapid shifts in central carbon metabolism.
Yu W; Chen Y; Dubrulle J; Stossi F; Putluri V; Sreekumar A; Putluri N; Baluya D; Lai SY; Sandulache VC
Sci Rep; 2018 Mar; 8(1):4306. PubMed ID: 29523854
[TBL] [Abstract][Full Text] [Related]
13. DNA Adducts from Anticancer Drugs as Candidate Predictive Markers for Precision Medicine.
Stornetta A; Zimmermann M; Cimino GD; Henderson PT; Sturla SJ
Chem Res Toxicol; 2017 Jan; 30(1):388-409. PubMed ID: 27936622
[TBL] [Abstract][Full Text] [Related]
14. Microdose-Induced Drug-DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice.
Zimmermann M; Wang SS; Zhang H; Lin TY; Malfatti M; Haack K; Ognibene T; Yang H; Airhart S; Turteltaub KW; Cimino GD; Tepper CG; Drakaki A; Chamie K; de Vere White R; Pan CX; Henderson PT
Mol Cancer Ther; 2017 Feb; 16(2):376-387. PubMed ID: 27903751
[TBL] [Abstract][Full Text] [Related]
15. Use of Accelerator Mass Spectrometry in Human Health and Molecular Toxicology.
Enright HA; Malfatti MA; Zimmermann M; Ognibene T; Henderson P; Turteltaub KW
Chem Res Toxicol; 2016 Dec; 29(12):1976-1986. PubMed ID: 27726383
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronan-Lysine Cisplatin Drug Carrier for Treatment of Localized Cancers: Pharmacokinetics, Tolerability, and Efficacy in Rodents and Canines.
Zhang T; Cai S; Groer C; Forrest WC; Yang Q; Mohr E; Douglas J; Aires D; Axiak-Bechtel SM; Selting KA; Swarz JA; Tate DJ; Bryan JN; Forrest ML
J Pharm Sci; 2016 Jun; 105(6):1891-1900. PubMed ID: 27155765
[TBL] [Abstract][Full Text] [Related]
17. Aberrant DNA damage response pathways may predict the outcome of platinum chemotherapy in ovarian cancer.
Stefanou DT; Bamias A; Episkopou H; Kyrtopoulos SA; Likka M; Kalampokas T; Photiou S; Gavalas N; Sfikakis PP; Dimopoulos MA; Souliotis VL
PLoS One; 2015; 10(2):e0117654. PubMed ID: 25659114
[TBL] [Abstract][Full Text] [Related]
18. Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo.
Rocha CR; Garcia CC; Vieira DB; Quinet A; de Andrade-Lima LC; Munford V; Belizário JE; Menck CF
Cell Death Dis; 2014 Oct; 5(10):e1505. PubMed ID: 25356874
[TBL] [Abstract][Full Text] [Related]
19. DNA-bound platinum is the major determinant of cisplatin sensitivity in head and neck squamous carcinoma cells.
Martens-de Kemp SR; Dalm SU; Wijnolts FM; Brink A; Honeywell RJ; Peters GJ; Braakhuis BJ; Brakenhoff RH
PLoS One; 2013; 8(4):e61555. PubMed ID: 23613873
[TBL] [Abstract][Full Text] [Related]
20. Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer.
Cimino GD; Pan CX; Henderson PT
Bioanalysis; 2013 Feb; 5(3):369-91. PubMed ID: 23394702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
